BioSpace News Archive

Continued growth momentum over first half of 2018

CollPlant announced the appointment of Dr. Wolfgang Ruttenstorfer to its board of directors, increasing the board to seven members.

Sernova Corp. announces that patient screening and recruitment has begun in its regenerative medicine US clinical trial for diabetic patients with hypoglycemia unawareness.

SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients.

Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Strasse, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms.

MNG Laboratories is pleased to announce that it has signed a Distribution Agreement with Pronto Diagnostics, a leading Israeli genomics company, to exclusively market its complete line of Clinical RNA Sequencing Services in Israel.

KCR is extending its service portfolio with Trial Execution Consulting to support clients in translating scientific objectives into operational activity.

Mike Allan joins Certis USA as Vice President, North America. In his position, Allan will lead Certis USA’s business in North America.

Neovii pharmaceuticals AG and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.

NovaBay® Pharmaceuticals, Inc. announces it has completed the most recent planned expansion of its salesforce by hiring of 7 sales representatives.